These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

241 related items for PubMed ID: 11030069

  • 1. Mild axonal neuropathy of children during treatment for acute lymphoblastic leukaemia.
    Reinders-Messelink HA, Van Weerden TW, Fock JM, Gidding CE, Vingerhoets HM, Schoemaker MM, Göeken LN, Bökkerink JP, Kamps WA.
    Eur J Paediatr Neurol; 2000; 4(5):225-33. PubMed ID: 11030069
    [Abstract] [Full Text] [Related]

  • 2. Clinical and electrophysiological studies in vincristine induced neuropathy.
    Pal PK.
    Electromyogr Clin Neurophysiol; 1999 Sep; 39(6):323-30. PubMed ID: 10499201
    [Abstract] [Full Text] [Related]

  • 3. Vincristine neurotoxicity in the presence of hereditary neuropathy.
    Trobaugh-Lotrario AD, Smith AA, Odom LF.
    Med Pediatr Oncol; 2003 Jan; 40(1):39-43. PubMed ID: 12426685
    [No Abstract] [Full Text] [Related]

  • 4. Vincristine-related neuropathy versus acute inflammatory demyelinating polyradiculoneuropathy in children with acute lymphoblastic leukemia.
    Brigo F, Balter R, Marradi P, Ferlisi M, Zaccaron A, Fiaschi A, Frasson E, Bertolasi L.
    J Child Neurol; 2012 Jul; 27(7):867-74. PubMed ID: 22241706
    [Abstract] [Full Text] [Related]

  • 5. Reversible vincristine-related flaccid paralysis in a child with acute lymphoblastic leukemia.
    Fioredda F, Micalizzi C, Lanciotti M, Dufour C, Lamba LD, Fiocchi I.
    Med Pediatr Oncol; 2002 Aug; 39(2):141-2. PubMed ID: 12116067
    [No Abstract] [Full Text] [Related]

  • 6. Decrease in motor performance in children with cancer is independent of the cumulative dose of vincristine.
    Hartman A, van den Bos C, Stijnen T, Pieters R.
    Cancer; 2006 Mar 15; 106(6):1395-401. PubMed ID: 16453332
    [Abstract] [Full Text] [Related]

  • 7. A trial to assess the efficacy of glutamic acid in prevention of vincristine-induced neurotoxicity in pediatric malignancies: a pilot study.
    Mokhtar GM, Shaaban SY, Elbarbary NS, Fayed WA.
    J Pediatr Hematol Oncol; 2010 Nov 15; 32(8):594-600. PubMed ID: 20921909
    [Abstract] [Full Text] [Related]

  • 8. Vincristine-induced neuropathy in childhood ALL (acute lymphoblastic leukemia) survivors: prevalence and electrophysiological characteristics.
    Jain P, Gulati S, Seth R, Bakhshi S, Toteja GS, Pandey RM.
    J Child Neurol; 2014 Jul 15; 29(7):932-7. PubMed ID: 23781018
    [Abstract] [Full Text] [Related]

  • 9. Nerve lesions after therapy for childhood acute lymphoblastic leukemia.
    Harila-Saari AH, Vainionpää LK, Kovala TT, Tolonen EU, Lanning BM.
    Cancer; 1998 Jan 01; 82(1):200-7. PubMed ID: 9428498
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. [Electrophysiological studies in vincristin-polyneuropathy (author's transl)].
    Mamoli B, Heiss WD, Podreka I, Turnheim M.
    EEG EMG Z Elektroenzephalogr Elektromyogr Verwandte Geb; 1980 Mar 01; 11(1):21-7. PubMed ID: 6773738
    [Abstract] [Full Text] [Related]

  • 12. Association of an inherited genetic variant with vincristine-related peripheral neuropathy in children with acute lymphoblastic leukemia.
    Diouf B, Crews KR, Lew G, Pei D, Cheng C, Bao J, Zheng JJ, Yang W, Fan Y, Wheeler HE, Wing C, Delaney SM, Komatsu M, Paugh SW, McCorkle JR, Lu X, Winick NJ, Carroll WL, Loh ML, Hunger SP, Devidas M, Pui CH, Dolan ME, Relling MV, Evans WE.
    JAMA; 2015 Feb 24; 313(8):815-23. PubMed ID: 25710658
    [Abstract] [Full Text] [Related]

  • 13. Vincristine-induced peripheral neuropathy in survivors of childhood acute lymphoblastic leukaemia.
    Tay CG, Lee VWM, Ong LC, Goh KJ, Ariffin H, Fong CY.
    Pediatr Blood Cancer; 2017 Aug 24; 64(8):. PubMed ID: 28139029
    [Abstract] [Full Text] [Related]

  • 14. Vincristine-induced vocal cord palsy: case report and review of the literature.
    Latiff ZA, Kamal NA, Jahendran J, Alias H, Goh BS, Syed Zakaria SZ, Jamal R.
    J Pediatr Hematol Oncol; 2010 Jul 24; 32(5):407-10. PubMed ID: 20505534
    [Abstract] [Full Text] [Related]

  • 15. Patient stratification based on prednisolone-vincristine-asparaginase resistance profiles in children with acute lymphoblastic leukemia.
    Den Boer ML, Harms DO, Pieters R, Kazemier KM, Gobel U, Körholz D, Graubner U, Haas RJ, Jorch N, Spaar HJ, Kaspers GJ, Kamps WA, Van der Does-Van den Berg A, Van Wering ER, Veerman AJ, Janka-Schaub GE.
    J Clin Oncol; 2003 Sep 01; 21(17):3262-8. PubMed ID: 12947061
    [Abstract] [Full Text] [Related]

  • 16. Vincristine in childhood leukaemia: no pharmacokinetic rationale for dose reduction in adolescents.
    Frost BM, Lönnerholm G, Koopmans P, Abrahamsson J, Behrendtz M, Castor A, Forestier E, Uges DR, de Graaf SS.
    Acta Paediatr; 2003 May 01; 92(5):551-7. PubMed ID: 12839283
    [Abstract] [Full Text] [Related]

  • 17. Bilateral vocal cord paralysis following treatment with vincristine.
    Naithani R, Dolai TK, Kumar R.
    Indian Pediatr; 2009 Jan 01; 46(1):68-9. PubMed ID: 19179723
    [Abstract] [Full Text] [Related]

  • 18. Modification of vincristine dosing during concomitant azole therapy in adult acute lymphoblastic leukemia patients.
    Harnicar S, Adel N, Jurcic J.
    J Oncol Pharm Pract; 2009 Sep 01; 15(3):175-82. PubMed ID: 19282418
    [Abstract] [Full Text] [Related]

  • 19. Motor nervous pathway function is impaired after treatment of childhood acute lymphoblastic leukemia: a study with motor evoked potentials.
    Harila-Saari AH, Huuskonen UE, Tolonen U, Vainionpää LK, Lanning BM.
    Med Pediatr Oncol; 2001 Mar 01; 36(3):345-51. PubMed ID: 11241435
    [Abstract] [Full Text] [Related]

  • 20. Itraconazole-enhanced vincristine neurotoxicity in a child with acute lymphoblastic leukemia.
    Jeng MR, Feusner J.
    Pediatr Hematol Oncol; 2001 Mar 01; 18(2):137-42. PubMed ID: 11255732
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 13.